Patil C, Rossa C, Kirkwood K L
Department of Oral Biology, State University of New York at Buffalo, Buffalo, NY, USA.
Oral Microbiol Immunol. 2006 Dec;21(6):392-8. doi: 10.1111/j.1399-302X.2006.00314.x.
Actinobacillus actinomycetemcomitans plays a major role in the pathogenesis of aggressive periodontitis. Lipopolysaccharide (LPS) derived from A. actinomycetemcomitans is a key factor in inflammatory cytokine generation within periodontal tissues. In this study, we identify major mitogen-activated protein kinase (MAPK) signaling pathways induced by A. actinomycetemcomitans LPS, Escherichia coli LPS and interleukin-1beta (IL-1beta) in a murine periodontal ligament (mPDL) fibroblast cell line. Immunoblot analysis was used to assess the phosphorylated forms of p38, extracellular-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) MAPK following stimulation with A. actinomycetemcomitans LPS, E. coli LPS and IL-1beta. IL-6 mRNA induction was detected via reverse transcription-polymerase chain reaction, while protein levels were quantified via enzyme-linked immunosorbent assays (ELISA). We utilized biochemical inhibitors of p38, ERK and JNK MAPK to identify the MAPK signaling pathways needed for IL-6 expression. Additional use of stable mPDL cell lines containing dominant negative mutant constructs of MAPK kinase-3 and -6 (MKK-3/6) and p38 null mutant mouse embryonic fibroblast (MEF) cells were used to substantiate the biochemical inhibitor data. Blocking p38 MAPK with SB203580 reduced the induction of IL-6 mRNA by A. actinomycetemcomitans LPS, E. coli LPS and IL-1beta by >70%, >95% and approximately 60%, respectively. IL-6 ELISA indicated that blocking p38 MAPK reduced the IL-6 protein levels induced by A. actinomycetemcomitans LPS, E. coli LPS and IL-1beta by approximately 60%, approximately 50% and approximately 70%, respectively. All MAPK inhibitors significantly reduced the IL-6 protein levels induced by A. actinomycetemcomitans LPS, E. coli LPS and IL-1beta whereas only p38 inhibitors consistently reduced the A. actinomycetemcomitans LPS, E. coli LPS and IL-1beta induction of IL-6 mRNA steady-state levels. The contribution of p38 MAPK LPS-induced IL-6 expression was confirmed using MKK-3/6 dominant negative stable mPDL cell lines. Wild-type and p38alpha(-/-) MEF cells provided additional evidence to support the role of p38alpha MAPK in A. actinomycetemcomitans LPS-stimulated IL-6. Our results indicate that induction of IL-6 by E. coli LPS, IL-1beta and A. actinomycetemcomitans LPS requires signaling through MKK-3-p38alpha ERK, JNK and p38 MAPK in mPDL cells.
伴放线放线杆菌在侵袭性牙周炎的发病机制中起主要作用。源自伴放线放线杆菌的脂多糖(LPS)是牙周组织内炎性细胞因子产生的关键因素。在本研究中,我们确定了伴放线放线杆菌LPS、大肠杆菌LPS和白细胞介素-1β(IL-1β)在小鼠牙周膜(mPDL)成纤维细胞系中诱导的主要丝裂原活化蛋白激酶(MAPK)信号通路。免疫印迹分析用于评估在用伴放线放线杆菌LPS、大肠杆菌LPS和IL-1β刺激后p38、细胞外调节激酶(ERK)和c-jun氨基末端激酶(JNK)MAPK的磷酸化形式。通过逆转录-聚合酶链反应检测IL-6 mRNA的诱导情况,而蛋白质水平通过酶联免疫吸附测定(ELISA)进行定量。我们利用p38、ERK和JNK MAPK的生化抑制剂来确定IL-6表达所需的MAPK信号通路。另外使用含有MAPK激酶-3和-6(MKK-3/6)显性负突变构建体的稳定mPDL细胞系以及p38基因敲除突变小鼠胚胎成纤维细胞(MEF)来证实生化抑制剂的数据。用SB203580阻断p38 MAPK可使伴放线放线杆菌LPS、大肠杆菌LPS和IL-1β诱导的IL-6 mRNA分别减少>70%、>95%和约60%。IL-6 ELISA表明,阻断p38 MAPK可使伴放线放线杆菌LPS、大肠杆菌LPS和IL-1β诱导的IL-6蛋白水平分别降低约60%、约50%和约70%。所有MAPK抑制剂均显著降低了伴放线放线杆菌LPS、大肠杆菌LPS和IL-1β诱导的IL-6蛋白水平,而只有p38抑制剂持续降低伴放线放线杆菌LPS、大肠杆菌LPS和IL-1β诱导的IL-6 mRNA稳态水平。使用MKK-3/6显性负稳定mPDL细胞系证实了p38 MAPK对LPS诱导的IL-6表达的作用。野生型和p38α(-/-)MEF细胞提供了额外证据,支持p38α MAPK在伴放线放线杆菌LPS刺激的IL-6中的作用。我们的结果表明,大肠杆菌LPS、IL-1β和伴放线放线杆菌LPS诱导IL-6需要通过mPDL细胞中的MKK-3-p38α ERK、JNK和p38 MAPK进行信号传导。